McGrath Yvonne 4
4 · iTeos Therapeutics, Inc. · Filed Jun 10, 2021
Insider Transaction Report
Form 4
McGrath Yvonne
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-06-08$20.00/sh−7,927$158,540→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-06-08−7,927→ 95,123 totalExercise: $4.23Exp: 2030-05-01→ Common Stock (1,402 underlying) - Exercise/Conversion
Common Stock
2021-06-08$4.23/sh+7,927$33,531→ 7,927 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2021.
- [F2]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date, subject to the reporting persons continuous service relationship with the Issuer through such date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting persons continuous service relationship with the Issuer through each applicable vesting date.